X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (142) 142
Publication (17) 17
Newspaper Article (15) 15
Conference Proceeding (13) 13
Book Chapter (10) 10
Book / eBook (9) 9
Book Review (2) 2
Dissertation (1) 1
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (44) 44
oncology (31) 31
male (28) 28
hematology (22) 22
animals (21) 21
female (21) 21
aged (13) 13
analysis (12) 12
middle aged (12) 12
adult (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
care and treatment (10) 10
chemotherapy (10) 10
lymphomas (10) 10
research (10) 10
abridged index medicus (9) 9
article (9) 9
activation (8) 8
biochemistry & molecular biology (8) 8
drug therapy (8) 8
pharmacology & pharmacy (8) 8
treatment outcome (8) 8
cancer (7) 7
cell biology (7) 7
cyclophosphamide (7) 7
gene expression (7) 7
stem cell transplantation (7) 7
therapy (7) 7
clinical trials (6) 6
genetic aspects (6) 6
lymphoma, follicular - drug therapy (6) 6
non-hodgkins-lymphoma (6) 6
adolescent (5) 5
dose-response relationship, drug (5) 5
immunology (5) 5
mutation (5) 5
neurosciences (5) 5
patients (5) 5
phosphorylation (5) 5
rats (5) 5
retrospective studies (5) 5
rituximab (5) 5
survival (5) 5
transplantation (5) 5
usage (5) 5
adenosine receptor (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
b-cell (4) 4
b-cell lymphoma (4) 4
bone-marrow-transplantation (4) 4
cardiac & cardiovascular systems (4) 4
diagnosis (4) 4
disease-free survival (4) 4
follicular lymphoma (4) 4
health aspects (4) 4
health care sciences & services (4) 4
health policy & services (4) 4
health services (4) 4
ligands (4) 4
mice (4) 4
nursing homes (4) 4
outcomes (4) 4
physiological aspects (4) 4
prevention (4) 4
risk factors (4) 4
schizophrenia (4) 4
stem cells (4) 4
studies (4) 4
time factors (4) 4
trial (4) 4
vincristine (4) 4
acute lymphoblastic-leukemia (3) 3
age factors (3) 3
aged, 80 and over (3) 3
biophysics (3) 3
brain - metabolism (3) 3
car t cell therapy (3) 3
cell line (3) 3
chemistry, medicinal (3) 3
child (3) 3
chronic lymphocytic leukemia (3) 3
combined modality therapy (3) 3
data collection (3) 3
disease (3) 3
disease progression (3) 3
drugs (3) 3
electronic books (3) 3
excess baff (3) 3
follow-up studies (3) 3
g protein-coupled receptor (3) 3
hematologic neoplasms - therapy (3) 3
homeostasis (3) 3
immunotherapy (3) 3
infectious diseases (3) 3
leukemia (3) 3
long-term care (3) 3
long-term care facilities (3) 3
lymphocytes (3) 3
lymphocytes b (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4, pp. 328 - 335
PURPOSE Anti-CD19-directed chimeric antigen receptor (CAR) T-cell therapy has had a resounding effect on the treatment of chemotherapy-insensitive aggressive... 
ACTIVATION | ONCOLOGY | NEUROTOXICITY | T-CELLS
Journal Article
Hematology/oncology clinics of North America, 08/2019, Volume 33, Issue 4, p. xiii
Journal Article
JAMA, ISSN 0098-7484, 07/2019, Volume 322, Issue 10, pp. 923 - 924
This Viewpoint discusses existing mechanisms of Medicare reimbursement for chimeric antigen receptor (CAR) T-cell therapy, which at US $375000 to $475000 per... 
MEDICINE, GENERAL & INTERNAL | PEDIATRIC-PATIENTS | Care and treatment | Usage | Microcosm and macrocosm | Genetic aspects | Research | Gene therapy | Cancer | Antigens | Therapy | Lymphocytes T | Medicare | Government programs
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2019, Volume 111, Issue 7, pp. 646 - 654
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary new form of immunotherapy for the treatment of hematologic malignancies. The two primary... 
BIOMARKERS | CHIMERIC ANTIGEN RECEPTORS | THERAPY | MANAGEMENT | B-CELL | ONCOLOGY | IMMUNOTHERAPY | REMISSIONS | BRAIN-BARRIER DISRUPTION | TOXICITY | BLINATUMOMAB
Journal Article
Expert opinion on biological therapy, ISSN 1471-2598, 07/2019, pp. 1 - 8
: Traditionally, outcomes for patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma have been poor. There has been a clear need for... 
Journal Article
Hematology/oncology clinics of North America, ISSN 0889-8588, 08/2019, Volume 33, Issue 4, pp. 687 - 687
Despite the myriad of available treatments, a substantial subset of patients with non-Hodgkin lymphoma are not able to achieve a prolonged disease-free... 
LONG-TERM SURVIVAL | MYCOSIS-FUNGOIDES | CONDITIONING REGIMENS | EUROPEAN-SOCIETY | WORKING PARTY | Non-Hodgkin lymphoma | RELAPSED FOLLICULAR LYMPHOMA | ONCOLOGY | Allogeneic stem cell transplant | MALIGNANCIES | Chimeric antigen receptor T-cell therapy | LEUKEMIA/LYMPHOMA | OUTCOMES | HEMATOLOGY | T-cell lymphoma | B-cell lymphoma | BLOOD
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12/2018, p. JCO1801457
Anti-CD19-directed chimeric antigen receptor (CAR) T-cell therapy has had a resounding effect on the treatment of chemotherapy-insensitive aggressive B-cell... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article
Expert review of hematology, 02/2019, p. 1
Chimeric antigen receptor (CAR) T cell immunotherapy has demonstrated remarkable anti-tumor activity in B-cell malignancies and is under investigation in other... 
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2019, Volume 20, Issue 1, pp. 31 - 42
Axicabtagene ciloleucel is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. In the previous analysis of the ZUMA-1 registrational study,... 
2-YEAR SURVIVORS | HODGKIN | CHIMERIC ANTIGEN RECEPTOR | OUTCOMES | ONCOLOGY | TRANSPLANTATION | Analysis | Lymphomas
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 2, pp. 195 - 203
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1163 - 1165
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.